BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33934137)

  • 21. A method for generation phage cocktail with great therapeutic potential.
    Gu J; Liu X; Li Y; Han W; Lei L; Yang Y; Zhao H; Gao Y; Song J; Lu R; Sun C; Feng X
    PLoS One; 2012; 7(3):e31698. PubMed ID: 22396736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological and genomic characteristics of three novel bacteriophages and a phage-plasmid of
    Uskudar-Guclu A; Unlu S; Salih-Dogan H; Yalcin S; Basustaoglu A
    Can J Microbiol; 2024 Jun; 70(6):213-225. PubMed ID: 38447122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a T7-like lytic bacteriophage of Klebsiella pneumoniae B5055: a potential therapeutic agent.
    Verma V; Harjai K; Chhibber S
    Curr Microbiol; 2009 Sep; 59(3):274-81. PubMed ID: 19484297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia.
    Jeon J; Park JH; Yong D
    BMC Microbiol; 2019 Apr; 19(1):70. PubMed ID: 30940074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice.
    Chhibber S; Kaur S; Kumari S
    J Med Microbiol; 2008 Dec; 57(Pt 12):1508-1513. PubMed ID: 19018021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phages against Noncapsulated Klebsiella pneumoniae: Broader Host range, Slower Resistance.
    Lourenço M; Osbelt L; Passet V; Gravey F; Megrian D; Strowig T; Rodrigues C; Brisse S
    Microbiol Spectr; 2023 Aug; 11(4):e0481222. PubMed ID: 37338376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and characterization of lytic phage TUN1 specific for Klebsiella pneumoniae K64 clinical isolates from Tunisia.
    Eckstein S; Stender J; Mzoughi S; Vogele K; Kühn J; Friese D; Bugert C; Handrick S; Ferjani M; Wölfel R; Millard A; Ben Moussa M; Bugert JJ
    BMC Microbiol; 2021 Jun; 21(1):186. PubMed ID: 34154528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence to support the therapeutic potential of bacteriophage Kpn5 in burn wound infection caused by Klebsiella pneumoniae in BALB/c mice.
    Kumari S; Harjai K; Chhibber S
    J Microbiol Biotechnol; 2010 May; 20(5):935-41. PubMed ID: 20519918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriophage ZCKP1: A Potential Treatment for
    Taha OA; Connerton PL; Connerton IF; El-Shibiny A
    Front Microbiol; 2018; 9():2127. PubMed ID: 30254618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A K-17 serotype specific Klebsiella phage JKP2 with biofilm reduction potential.
    Asif M; Alvi IA; Waqas M; Basit A; Raza FA; Rehman SU
    Virus Res; 2023 May; 329():199107. PubMed ID: 36996938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic Characterization and Efficacy of Bacteriophage Cocktails Infecting
    Manohar P; Tamhankar AJ; Lundborg CS; Nachimuthu R
    Front Microbiol; 2019; 10():574. PubMed ID: 30949158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo efficacy of single phage versus phage cocktail in resolving burn wound infection in BALB/c mice.
    Chadha P; Katare OP; Chhibber S
    Microb Pathog; 2016 Oct; 99():68-77. PubMed ID: 27498362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic characterization of a new phage BUCT541 against
    Pu M; Li Y; Han P; Lin W; Geng R; Qu F; An X; Song L; Tong Y; Zhang S; Cai Z; Fan H
    Front Microbiol; 2022; 13():950737. PubMed ID: 36187954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the therapeutic effect of a novel bacteriophage in the healing process of infected wounds with Klebsiella pneumoniae in mice.
    Kelishomi FZ; Nikkhahi F; Amereh S; Ghayyaz F; Marashi SMA; Javadi A; Shahbazi G; Khakpour M
    J Glob Antimicrob Resist; 2024 Mar; 36():371-378. PubMed ID: 38307250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topically Applied Bacteriophage to Control Multi-Drug Resistant
    Fayez MS; Hakim TA; Agwa MM; Abdelmoteleb M; Aly RG; Montaser NN; Abdelsattar AS; Rezk N; El-Shibiny A
    Antibiotics (Basel); 2021 Aug; 10(9):. PubMed ID: 34572629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Bacteriophage Cocktail on Septicemia Caused by Colistin-Resistant
    Singh A; Singh AN; Rathor N; Chaudhry R; Singh SK; Nath G
    Front Pharmacol; 2022; 13():778676. PubMed ID: 35197852
    [No Abstract]   [Full Text] [Related]  

  • 37. Bacteriophage cocktail shows no toxicity and improves the survival of
    Kelly L; Jameson E
    J Virol; 2024 Jun; 98(6):e0027224. PubMed ID: 38771043
    [No Abstract]   [Full Text] [Related]  

  • 38. Morphological, biological, and genomic characterization of Klebsiella pneumoniae phage vB_Kpn_ZC2.
    Fayez MS; Hakim TA; Zaki BM; Makky S; Abdelmoteleb M; Essam K; Safwat A; Abdelsattar AS; El-Shibiny A
    Virol J; 2023 May; 20(1):86. PubMed ID: 37138257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolating and sequencing vB_Kpn_3, a lytic bacteriophage against multidrug-resistant 
    Habibinava F; Soleimani M; Sabouri S; Zargar M; Zolfaghari MR
    Future Microbiol; 2022 Mar; 17():235-249. PubMed ID: 35152708
    [No Abstract]   [Full Text] [Related]  

  • 40. Liposome loaded phage cocktail: Enhanced therapeutic potential in resolving Klebsiella pneumoniae mediated burn wound infections.
    Chadha P; Katare OP; Chhibber S
    Burns; 2017 Nov; 43(7):1532-1543. PubMed ID: 28502784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.